glp-1 obesity drug news today september 15 2025 Alarming rise in weight loss overdoses Use of diabetes and anti-obesity

Insulin Secretion Models: Investigating glucose-dependent signaling pathways

Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, et al

Introduction Dementia and Alzheimers disease (AD) have long been framed as primarily neurological disorders, but a growing body of evidence suggests they are deeply intertwined with metabolic, vascular, and inflammatory dysfunction

doi: 10.1016/j.jns.2016.10.052 41 DengW.SaxeM

For a smaller group of patients, symptoms interfere with work, sleep, and social activities

As blood sugar decreases, Semaglutide GLP-1 increases insulin release decreases glucagon release and delays gastric emptying